check_circleStudy Completed

Erectile Dysfunction

BAY38-7268, ODT formulation finding CIMA

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

21 - 44 Years
  • -

  • -

Trial summary

Enrollment Goal
13
Trial Dates
April 2005 - May 2005
Phase
N/A
Could I Receive a placebo
N/A
Products
Vardenafil ODT (BAY38-9456)
Accepts Healthy Volunteer
N/A

Where to participate

StatusInstitutionLocation
Completed
MEDA Manufacturing GmbH, ClinPharmCologneKöln, 51063, Germany

Trial design

Randomized, open-label, two-fold crossover study to investigate the relative bioavailability of a 10 mg vardenafil oral disintegrating tablet in comparison to a 10 mg vardenafil standard tablet after single oral dosing in healthy male subjects
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A